orlyvardeny (@orlyvardeny) 's Twitter Profile
orlyvardeny

@orlyvardeny

ID: 1242860768527294465

calendar_today25-03-2020 17:08:02

231 Tweet

187 Followers

211 Following

Maria A. Pabón, MD (@mapabonp) 's Twitter Profile Photo

Out now in JACC Journals! Our study showing that finerenone reduces the risk of new-onset AF by ~20% in high-risk CKM patients.📉✨ jacc.org/doi/10.1016/j.… Grateful to my co-authors & mentors Muthu Vaduganathan and scottdavidsolomon for their support! #CardioTwitter #CKM #AFib

Out now in <a href="/JACCJournals/">JACC Journals</a>! Our study showing that finerenone reduces the risk of new-onset AF by ~20% in high-risk CKM patients.📉✨
jacc.org/doi/10.1016/j.…

Grateful to my co-authors &amp; mentors <a href="/mvaduganathan/">Muthu Vaduganathan</a>  and <a href="/scottdsolomon/">scottdavidsolomon</a> for their support! #CardioTwitter #CKM #AFib
HFSA (@hfsa) 's Twitter Profile Photo

Calling all Women in HF ❤️ Join us for a FREE webinar on May 6 at 7 PM ET as a panel of experts discuss academic promotion for women in heart failure. Register now:hfsa.org/event/hfsa-wom…

Calling all Women in HF ❤️ Join us for a FREE webinar on May 6 at 7 PM ET as a panel of experts discuss academic promotion for women in heart failure.

Register now:hfsa.org/event/hfsa-wom…
Rebecca Cogswell (@rcogswell_umn) 's Twitter Profile Photo

💥 Don't miss the University of Minnesota Heart Failure Symposium on Friday, May 16! ✅ Keynote by Dr. James C. Fang ✅ HFSA-endorsed ✅ Earn CME ✅ Latest in HF care, temp support & advanced therapies 🔗 Register now: med.umn.edu/dom/divisions/… #HeartFailure #CME #Cardiology

Muthu Vaduganathan (@mvaduganathan) 's Twitter Profile Photo

The HF world comes together this week in Belgrade #HeartFailure2025 Opening #LBCT session is absolutely 🔥 & not to be missed. We are delighted to present the blinded withdrawal phase following #FINEARTSHF What happens if you stop/withdraw a HF therapy? esc365.escardio.org/Heart-Failure/…

The HF world comes together this week in Belgrade #HeartFailure2025

Opening #LBCT session is absolutely 🔥 &amp; not to be missed. We are delighted to present the blinded withdrawal phase following #FINEARTSHF

What happens if you stop/withdraw a HF therapy?

esc365.escardio.org/Heart-Failure/…
HFAPresident (@hfa_president) 's Twitter Profile Photo

HFA Eugene Braunwald Lecture by Dr. Lynne Stevenson — celebrating her groundbreaking contributions and lasting impact on the world of heart failure. A true pioneer! #HeartFailure2025 Novi Yanti Sari Wilfried Mullens Amr Abdin European Society of Cardiology

HFA Eugene Braunwald Lecture by Dr. Lynne Stevenson — celebrating her groundbreaking contributions and lasting impact on the world of heart failure. A true pioneer! #HeartFailure2025 
<a href="/slumberbell/">Novi Yanti Sari</a> <a href="/WilfriedMullens/">Wilfried Mullens</a> <a href="/AmrAbdin10/">Amr Abdin</a> <a href="/escardio/">European Society of Cardiology</a>
Circ: Heart Failure (@circhf) 's Twitter Profile Photo

#CircHF Simultaneous Publication with #HeartFailure2025 from Senthil Selvaraj, MD, MS, MA & Vishal Rao et al: Late-Life Echocardiographic Effects of the Amyloidogenic p.V142I Transthyretin Variant Read more➡️ahajournals.org/doi/10.1161/CI… #AHAJournals Michel Khouri AHA Science

Peder L. Myhre MD, PhD (@pmyhre) 's Twitter Profile Photo

Super interesting data from Safia Chatur, MD scottdavidsolomon and #FINEARTS-HF: Consistent safety and efficacy of finerenone across the eGFR spectrum in HF, and seems more favorable with respect to safety in lower eGFR compared to spironolactone (TOPCAT)

Super interesting data from <a href="/safchat/">Safia Chatur, MD</a> <a href="/scottdsolomon/">scottdavidsolomon</a> and #FINEARTS-HF:

Consistent safety and efficacy of finerenone across the eGFR spectrum in HF, and seems more favorable with respect to safety in lower eGFR compared to spironolactone (TOPCAT)
Andrew P. Ambrosy, MD, MPH (@kpheartdoc) 's Twitter Profile Photo

HFpEF affects ~4M in the U.S. Once lacking therapies, HFpEF is now seeing rapid progress—with SGLT2i, Ns-MRAs, and GLP-1 RAs offering hope, especially for the obesity phenotype. (link.springer.com/article/10.100…). #HREV Josephine Harrington, MD Marc Bonaca MD MPH Andrew J Sauer MD orlyvardeny Mario Enrico Canonico

Maria A. Pabón, MD (@mapabonp) 's Twitter Profile Photo

FINEARTS-HF is the 2nd large RCT to include patients with #HFimpEF. Out now🚨 our new JAMA Cardiology analysis shows that finerenone confers benefit in this group, despite their persistent risk of adverse outcomes jamanetwork.com/journals/jamac… Muthu Vaduganathan scottdavidsolomon orlyvardeny

FINEARTS-HF is the 2nd large RCT to include patients with #HFimpEF. Out now🚨 our new <a href="/JAMACardio/">JAMA Cardiology</a> analysis shows that finerenone confers benefit in this group, despite their persistent risk of adverse outcomes
jamanetwork.com/journals/jamac…
<a href="/mvaduganathan/">Muthu Vaduganathan</a> <a href="/scottdsolomon/">scottdavidsolomon</a> <a href="/orlyvardeny/">orlyvardeny</a>
JAMA Cardiology (@jamacardio) 's Twitter Profile Photo

Patients with heart failure and HFimpEF remain at high risk for cardiovascular events, but finerenone consistently reduces this risk without significant adverse effects. ja.ma/4jjmY0T orlyvardeny Muthu Vaduganathan Sanjiv J. Shah, MD Adriaan Voors clara saldarriaga

Patients with heart failure and HFimpEF remain at high risk for cardiovascular events, but finerenone consistently reduces this risk without significant adverse effects. ja.ma/4jjmY0T <a href="/orlyvardeny/">orlyvardeny</a> <a href="/mvaduganathan/">Muthu Vaduganathan</a> <a href="/HFpEF/">Sanjiv J. Shah, MD</a> <a href="/AdriaanVoors/">Adriaan Voors</a> <a href="/clara_clarais/">clara saldarriaga</a>
Circ: Heart Failure (@circhf) 's Twitter Profile Photo

📣Calling all #AHFTC Fellows! Circ: Heart Failure is proud to launch a free educational webinar series for current or past AHFTC fellows. 📍8 live virtual sessions, 1 in-person event 📍New topic each session 📅Start Date: August 13, 2025 🔗Learn More: ahajournals.org/circheartfailu…

📣Calling all #AHFTC Fellows! 

<a href="/CircHF/">Circ: Heart Failure</a> is proud to launch a free educational webinar series for current or past AHFTC fellows. 

📍8 live virtual sessions, 1 in-person event
📍New topic each session 

📅Start Date: August 13, 2025

🔗Learn More: ahajournals.org/circheartfailu…
Muthu Vaduganathan (@mvaduganathan) 's Twitter Profile Photo

#ACHIEVE largest CVOT (n=2538) of spiro in dialysis neutral CV benefit #ERA25 sMRA in CKM: RALES ✅ EPHESUS ✅ EMPHASIS ✅ TOPCAT ❓ BARACKD ❌ CLEAR ❌ ALCHEMIST ❌ ACHIEVE ❌ SPIRIT SPIRRIT nsMRA in CKM: FIDELIO ✅ FIGARO ✅ FINEARTS✅ CONFIRMATION REDEFINE FINALITY BalanceD

#ACHIEVE largest CVOT (n=2538) of spiro in dialysis neutral CV benefit #ERA25

sMRA in CKM:
RALES ✅
EPHESUS ✅
EMPHASIS ✅
TOPCAT ❓
BARACKD ❌
CLEAR ❌
ALCHEMIST ❌
ACHIEVE ❌
SPIRIT
SPIRRIT

nsMRA in CKM:
FIDELIO ✅
FIGARO  ✅
FINEARTS✅
CONFIRMATION
REDEFINE
FINALITY
BalanceD
JACC Journals (@jaccjournals) 's Twitter Profile Photo

From ignored to essential: #HeartFailure with improved EF isn’t a footnote anymore. This #JACC review charts a path from vague definitions to clinical clarity. jacc.org/doi/10.1016/j.… #HFimpEF #LVEF

From ignored to essential: #HeartFailure with improved EF isn’t a footnote anymore. This #JACC review charts a path from vague definitions to clinical clarity. jacc.org/doi/10.1016/j.…

#HFimpEF #LVEF
HFSA (@hfsa) 's Twitter Profile Photo

3 Ways to Save on HFSA Membership 👇 ❤️ First-time members get 50% off HFSA Membership ❤️ HFSA Members receive discounted ASM registration ❤️ ASM Early Bird registration is now open Sign up for HFSA Membership before June 30 to take advantage of these benefits and more!

3 Ways to Save on HFSA Membership 👇

❤️ First-time members get 50% off HFSA Membership
❤️ HFSA Members receive discounted ASM registration
❤️ ASM Early Bird registration is now open

Sign up for HFSA Membership before June 30 to take advantage of these benefits and more!
Maria A. Pabón, MD (@mapabonp) 's Twitter Profile Photo

HFimpEF is on the rise, but recovery isn’t the end of the story. Our latest review dives into what we know (and don’t) about its prognosis, treatment, and outcomes jacc.org/doi/full/10.10…

HFimpEF is on the rise, but recovery isn’t the end of the story. Our latest review dives into what we know (and don’t) about its prognosis, treatment, and outcomes jacc.org/doi/full/10.10…
Andrew P. Ambrosy, MD, MPH (@kpheartdoc) 's Twitter Profile Photo

Congrats to @AnkeetBhattMD and the KP-VACCINATE team! ~4 million adults randomized in 4 weeks—the largest RCT ever fully embedded in a LHS. Testing CV-focused vs. usual care messaging to improve flu vaccination. Results soon. (sciencedirect.com/science/articl…). Tor Biering-Sørensen, MD, MSc, MPH, PhD Muthu Vaduganathan